ClinicalTrials.gov
public full text
Public Domain
An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
The purpose of this study is to learn how treatment with acetyl-L-carnitine (ALCAR) will affect the hearts of patients with Friedreich's Ataxia as well as how it may affect other symptoms of Friedreich's Ataxia such as difficulties with balance, walking, or upper arm function.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy of Intravenous Immune Globulin in Treating Spinocerebellar Ataxia#858764
- Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis#813241
- Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic Counseling#1351098
- Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride#994531
- Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients#1295994
Record · ID 1183939
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive